LifeSplice Pharma LLC is an American private company. The firm develops drugs for neurological and non-neurological diseases.

Yinfeng Gene Technology Co., Ltd., established on 2015-08-07, Business scope includes general items:Development of Human Gene Diagnosis and Therapy Technology;Medical Research and Experimental Development;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Class I Medical Device Leasing;Sales of Class II Medical Devices;Class II Medical Device Leasing;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of experimental analysis instruments;Experimental analysis instrument sales;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Mechanical equipment research and development;software development;Manufacturing of computer software, hardware and peripheral equipment;Wholesale of computer software, hardware and auxiliary equipment;Retailing of computer software, hardware and auxiliary equipment;Sales of hygiene products and single-use medical products;Auto New Car Sales;Health Consulting Services(Does not include medical services);Remote Health Management Services;Healthy food(prepackaged)Sales;food sales(Only sell prepackaged food);Sales of formula food for special medical purposes;Food Internet Sales(Only sell prepackaged food);Manufacturing of wearable smart devices;Wearable smart device sales;Instrument Manufacturing;Instrument sales;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:medical service;Inspection and testing service;pharmaceutical production;Production of Class II Medical Devices;Class III medical device business;Production of Class III Medical Devices;Class III Medical Device Leasing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shanghai Jienuo Biological Technology Co., Ltd. is a private company headquartered in Shanghai, China. The firm supplies medical devices and vitro diagnostic reagents. It was founded in 1991. Xiao Kai Xia is currently the CEO of the company.

Yinfeng Bioengineering Group Co., Ltd., established on 2011-04-19, Business scope includes general items:R&D and application of cell technology;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Health Consulting Services(Does not include medical services);Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Daily necessities sales;Maternal and baby products sales;Cosmetics Wholesale;Cosmetics Retail.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business;Health food sales;Cosmetic production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

NEONC Technologies, Inc. (NTI) is an early-stage cancer biotechnology company focused initially on intranasal (delivery through the nose) inhalation and other nontraditional delivery of a novel, highly purified form of monoterpenes (oils from fruits & plants), alone or with other chemotherapeutics (cancer treatment chemicals) agents. It will initially be used in clinical research for first-line treatment of malignant brain cancer (gliomas) and other aggressive brain cancers, and later for the treatment of lung cancer. NTI was incorporated in the State of Delaware in 2008. The Company has assembled a highly qualified management team and board of directors. NTI is developing several proprietary molecules for clinical research some of which have demonstrated significant activity (positive results) in laboratory tests; NTI is accordingly building a portfolio of intellectual property around this research. In addition, the Company has reached an agreement with a manufacturer of active pharmaceutical ingredients for the development and production of proprietary monoterpenes.

Zhenjiang Weiss Biotechnology Co., Ltd., established on 2019-08-28, Business scope includes biotechnology research and development,Technology Promotion,technical consulting;Testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom.

Abbott Healthcare Products BV, part of Abbott Laboratories, is a company headquartered in Weesp, the Netherlands, that manufactures and distributes pharmaceuticals.

Ascle Pharmaceuticals (Zhejiang) Co., Ltd., established on 2014-09-24, Business scope includes pharmaceutical production,Sales;medicinal compound,chemical drug research,technology development,technology transfer;Anti-infective,Research on anti-cancer and other new drugs,technology development,Technical Services,Technology Transfer and Technology Consulting;Import and export.

Takeda California (TCAL) leverages technical strength in structure-based drug design, biologics, and gene expression analysis to efficiently generate potential new medicines aligned with Takeda’s global market strategies. The Company is located in San Diego, a premiere biotechnology community full of collaboration opportunities and growth potential. TCAL scientists invented Nesina, approved in multiple countries for the treatment of type 2 diabetes, and the staff has advanced multiple preclinical programs for the treatment of diabetes, obesity, cancer, and various immune and CNS disorders. The Company also hosts Takeda's proprietary bacTRAP technology, which provides a molecular atlas of gene expression with unprecedented cellular resolution to enable the discovery of new drug targets with selective mechanisms of action. TCAL strives to nurture employee development by providing a wide range of learning opportunities. Staff members are also highly engaged in community service, frequently organizing events in support of area schools, charitable foundations, and the environment.

National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON.

It offers its commercial partners scientifically backed, evidence-based products which are in high demand from multiple channels including veterinarians, farmers and producers, pet owners and retailers.It maintains the highest manufacturing standards and is a proud member of the NASC, a self-regulating body, which protects and enhances the integrity of the animal health product industry.It is actively collaborating with companies in Canada, the United States, Korea, Viet Nam, and Thailand, and we are seeking more relationships internationally.

Conler Pharm is a manufacturer of paracetamol and paracetamol DC. The company provides products like products are famotidine tablets, acetaminophen tablets, compound paracetamol tablets, polygeline injection, erdosteine capsules, compound paracetamol and chlorphenamine maleate granules, pediatric paracetamol, artificial cow-bezoar and chlorphenamine maleate granules and etc. The company also provides medical equipment.